CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BrightGene Bio-Medical Technology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BrightGene Bio-Medical Technology Co Ltd
Building C25-28, No.218 Xinghu Road, Sip
Phone: +86 51262620988p:+86 51262620988 SUZHOU, JNG  215123  China Ticker: 688166688166

Business Summary
BrightGene Bio-Medical Technology Co., Ltd. is a China-based company mainly engaged in chemical pharmaceutical business. The Company is engaged in the research, development and manufacture of pharmaceutical intermediates, APIs and preparation products for high-tech barriers. The Company is a research driven chemical and pharmaceutical industry chain product and technology platform enterprise that develops and participates in international competition. The Company's main products are Caspofungin, Entecavir, Micafungin, Anifenin, Pimecrolimus, Anthracycline, etc. The Company operates its businesses in both domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018Yes----

General Information
Number of Employees: 558 (As of 3/31/2019)
Outstanding Shares: 410,000,000 (As of 11/8/2019)
Stock Exchange: SHA
Fax Number: +86 51262551799


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 14, 2019